Global Strategy for Asthma Management and Prevention.

Global Initiative for Asthma

(GINA), 2006. Available from www.ginasthma.org Date last updated, 2006
Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary
of the GINA Dissemination Committee report. Allergy 2004;59:469-78.
Van Wonderen KE, Van Der Mark LB, Mohrs J, Bindels PJE, Van Aalderen WMC, Ter
Riet G. Different definitions in childhood asthma: how dependable is the dependent
variable? Eur Respir J 2010;36:48-56.
Lai CKW, Beasley R, Crane J, et al. Global variation in the prevalence and severity of
asthma symptoms: phase three of the International Study of Asthma and Allergies in
Childhood (ISAAC). Thorax 2009;64:476-83.
Pearce N, Ait-Khaled N, Beasley R, et al. Worldwide trends in the prevalence of asthma
symptoms: phase III of the International Study of Asthma and Allergies in Childhood
(ISAAC). Thorax 2007;62:758-66.
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes
of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden
of Disease Study 2010. Lancet 2013;380:2095-128.
http://www.healio.com/pediatrics/curbside-consultation/%7B33b52044-2e61-48ed-a163c6ff55816867%7D/which-groups-of-children.
Chivu RD, Chivu LI, Bradu-Iamandescu . Recent data in Allergology. InfoMedica 2006,
nr 3 (137).
G. John Gibson, Robert Loddenkemper, Yves Sibille, Bo Lundback.European Respiratory
Society.European

lung

white

book.2013;11:130-131.

Available

at

http://www.erswhitebook.org/chapters/childhood-asthma/
Akinbami LJ. The state of childhood asthma, United States, 19802005. Advance Data
from Vital and Health Statistics; No 381. Hyattsville, Md: National Center for Health
Statistics; 2006. Available at: http://www.cdc.gov/nchs/data/ad/ad381.pdf. Accessed June
2009

Global strategy for asthma management and prevention. Global Initiative for Asthma
(GINA). National Institutes of Health. NIH Publication No. 02-3659. Bethesda, Md:
National Heart, Lung, and Blood Institute (NHLBI); 2005.
Holgate ST. Genetic and environmental interaction in allergy and asthma. J Allergy Clin
Immunol 1999;104:1139-46
Ober C, Vercelli D. Gene-environment interactions in human disease: nuisance or
opportunity? Trends Genet 2011;27:107-15.
Ober C, Yao T-C. The genetics of asthma and allergic disease: a 21st century perspective.
Immunol Rev 2011;242:10-30.
Torgerson DG, Ampleford EJ, Chiu GY, et al. Meta-analysis of genome-wide association
studies of asthma in ethnically diverse North American populations. Nature Genetics
2011;43:887-92.
Brooks C, Pearce N, Douwes J. The hygiene hypothesis in allergy and asthma: an update.
Curr Opin Allergy Clin Immunol 2013;13:70-7.
Postma DS, Bleecker ER, Amelung PJ, et al. Genetic susceptibility to asthma--bronchial
hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med
1995;333:894-900.
Horwood LJ, Fergusson DM, Shannon FT. Social and familial factors in the development
of early childhood asthma. Pediatrics 1985;75:859-68.
Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and
wheezing in the first six years of life. The Group Health Medical Associates. N Engl J
Med 1995;332:133-8.
Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests.
Eur Respir J 2005;26:948-68.
Nepomnyaschy L, Reichman NE. Low birthweight and asthma among young urban
children. Am J Public Health. 2006;96:1604-1610.

Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen
(Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med
1990;323:502-7.
Wahn U, Lau S, Bergmann R, et al. Indoor allergen exposure is a risk factor for
sensitization during the first three years of life. J Allergy Clin Immunol 1997;99:763-9.
Hogaboam CM, Carpenter KJ, Schuh JM, Buckland KF. Aspergillus and asthma--any
link? Med Mycol 2005;43 Suppl 1:S197-202.
Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after
severe RSV bronchiolitis in the first year of life. Thorax 2010;65:1045-52.
Sly PD, Kusel M, Holt PG. Do early-life viral infections cause asthma? J Allergy Clin
Immunol 2010;125:1202-5.
Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of
wheeze and allergy by age 13 years. Lancet 1999;354:541-5.
Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life
predict asthma development in high-risk children. Am J Respir Crit Care Med
2008;178:667-72.
Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. Synergism
between allergens and viruses and risk of hospital admission with asthma: case-control
study. BMJ 2002;324:763.
Murray CS, Poletti G, Kebadze T, et al. Study of modifiable risk factors for asthma
exacerbations: virus infection and allergen exposure increase the risk of asthma hospital
admissions in children. Thorax 2006;61:376-82.
D. J. Jackson, R. E. Gangnon, M. D. Evans et al., Wheezing rhinovirus illnesses in early
life predict asthma development in high-risk children, American Journal of Respiratory
and Critical Care Medicine, vol. 178, no. 7, pp. 667672, 2008.
Gauderman WJ, Avol E, Gilliland F, et al. The effect of air pollution on lung development
from 10 to 18 years of age. N Engl J Med 2004;351:1057-67.

Wong GW, Lai CK. Outdoor air pollution and asthma. Curr Opin Pulm Med 2004;10:626.
Breysse PN, Diette GB, Matsui EC, Butz AM, Hansel NN, McCormack MC. Indoor air
pollution and asthma in children. Proc Am Thorac Soc 2010;7:102-6.
Burke H, Leonardi-Bee J, Hashim A, et al. Prenatal and passive smoke exposure and
incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics
2012;129:735-44.
Dezateux C, Stocks J, Dundas I, Fletcher ME. Impaired airway function and wheezing in
infancy: the influence of maternal smoking and a genetic predisposition to asthma. Am J
Respir Crit Care Med 1999;159:403-10.
Friedman NJ, Zeiger RS. The role of breast-feeding in the development of allergies and
asthma. J Allergy Clin Immunol 2005;115:1238-48.
Devereux G, Seaton A. Diet as a risk factor for atopy and asthma. J Allergy Clin Immunol
2005;115:1109-17.
Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a
complex, heterogeneous disease. Lancet 2008;372:1107-19.
Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med 2006;355:2226-35.
Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti- IgE recombinant humanized
monoclonal antibody for the treatment of severe allergic asthma. J Allergy Clin Immunol.
2001;108: 184190.
Grainge CL, Lau LC, Ward JA, et al. Effect of bronchoconstriction on airway remodeling
in asthma. N Engl J Med 2011;364:2006-15.
Groneberg DA, Quarcoo D, Frossard N, Fischer A. Neurogenic mechanisms in bronchial
inflammatory diseases. Allergy 2004;59:1139-52.
Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. J Allergy Clin Immunol
2011;128:451-62.

Lotvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: a new approach to
classification of disease entities within the asthma syndrome. J Allergy Clin Immunology
2011;127:355-60.
Barnes PJ. Is asthma a nervous disease? The Parker B. Francis lectureship. Chest
1995;107(Suppl. 3):119S25S [Epub 1995/03/01].
Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with
newly diagnosed asthma. Am Rev Respir Dis 1993;147(3):697704 [Epub 1993/03/01].
ODonnell RA, Davies DE, Holgate ST. Airway remodelling. In: Barnes P, Drazen J,
Rennard S, Thomson N, editors. Asthma and COPD. London: Academic Press; 2002.
Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma.
Thorax 1998;53(2):12936 [Epub 1998/06/13].
Grainge CL, Lau LC, Ward JA, Dulay V, Lahiff G, Wilson S, et al. Effect of
bronchoconstriction on airway remodeling in asthma. N Engl J Med 2011;364(21):2006
15 [Epub 2011/05/27].
Brand PLP, Baraldi E, Bisgaard H, et al. Definition,assessment and treatment of wheezing
disorders in preschool children: an evidence-based approach. Eur Respir J 2008;32:1096
110.
British Thoracic Society (BTS), Scottish Intercollegiate Guidelines Network (SIGN).
British guideline on the management of asthma: a national clinical guideline.Available
from:

https://www.brit-thoracic.org.uk/document-library/clinical-

information/asthma/btssign-guideline-on-the-management-of-asthma/.Accessed May 16,

2014.
Cane RS, Ranganathan SC, McKenzie SA. What do parents of wheezy children
understand by wheeze? Arch Dis Child 2000;82:32732.
Cane RS, McKenzie SA. Parents interpretations of childrens respiratory symptoms on
video. Arch Dis Child 2001;84:31 4.
Mellis C. Respiratory noises: how useful are they clinically? Pediatr Clin North Am
2009;56:1-17, ix.

Van Der Heijden HH, Brouwer ML, Hoekstra F, Van Der Pol P, Merkus PJ. Reference
values of exhaled nitric oxide in healthy children 1-5 years using off-line tidal breathing.
Pediatr Pulmonol 2014;49:291-5.
L. Hendeles, J. Sherman Are inhaled corticosteroids effective for acute exacerbations of
asthma in children? J Pediatr., 142 (2003), pp. S26S33.
G. Herrmann, M.B. Aynesworth Successful treatment of persistent extreme dyspnea
status asthmaticus J Lab Clin Med., 23 (1937), pp. 135148.
G. Phillip, C.M. Hustad, M.-P. Jalice, et al.Analysis of behavior-related adverse
experiences in clinical trials of montelukast J Allergy Clin Immunol., 124 (2009), pp.
699706.
H.M. Corneli, J.J. Zorc, P. Majahn, et al. A multicenter, randomized, controlled trial of
dexamethasone for bronchiolitis N Engl J Med., 357 (2007), pp. 331339.
B.L. Sinclair, D.W. Clark, M.R. Sears How well do New Zealand patients understand and
manage their asthma? A community study N Z Med J., 100 (1987), pp. 674677
Baena-Cagnani CE, Badellino HA. Diagnosis of allergy and asthma in childhood. Curr
Allergy Asthma Rep 2011;11:717.
Global Initiative for Asthma (GINA). Global strategy for the diagnosis and management
of

asthma

in

children

years

http://www.ginasthma.org/Global-Strategy-forthe-

and

younger.

Available

from:

Diagnosisand-Management-of-

Asthma-in- Children-5-Years-and-Younger. Updated May 2009. Accessed May 16, 2014.

British Thoracic Society (BTS), Scottish Intercollegiate Guidelines Network (SIGN).
British guideline on the management of asthma: a national clinical guideline. Available
from:

https://www.brit-thoracic.org.uk/

document-library/clinical-information/asthma/

btssign-guideline-on-the-management-of-asthma/. Accessed May16, 2014.

World Health Organization (WHO). Global surveillance, prevention and control of
chronic respiratory diseases: a comprehensive approach, 2007. Available from:
http://www.who.int/gard/publications/GARD_ Manual/en/. Accessed May 16, 2014.
Roberts G. Predicting the long-term outcome of preschool wheeze: are we there yet? J
Allergy Clin Immunol 2009;124:91112.

Castro-Rodriguez JA. The Asthma Predictive Index: early diagnosis of asthma. Curr Opin
Allergy Clin Immunol 2011;11:157 61.
Pedersen SE, Hurd SS, Lemanske RF Jr, et al.Global strategy for the diagnosis and
management of asthma in children 5 years and younger. Pediatr Pulmonol 2011;46:117.
Global Initiative for Asthma (GINA). Pocket guide for asthma management and
prevention

in

children

years

and

younger.

Available

from:

http://www.ginasthma.org/Global-Strategy-forthe-Diagnosisand- Management of-Asthmain-Children-5-Years-and- Younger. Updated May 2009. Accessed May 16, 2014.
Finnvold JE. In their own words: early childhood asthma and parents experiences of the
diagnostic process. Scand J Caring Sci 2010;24:299 306.
Bacharier LB, Gilbert TW. Diagnosis and management of early asthma in preschool-aged
children. J Allergy Clin Immunol 2012;130:28796.
Bush A. Diagnosis of asthma in children under five. Prim Care Respir J 2007;16:715.
Pedersen S. Preschool asthmanot so easy to diagnose. Prim Care Respir J 2007;16:46.
National Asthma Education and Prevention Program (NAEPP). Expert Panel Report 3:
Guidelines for the Diagnosis' and Nanagement of Asthma, Full Report 200Z Bethesda,
Md: National Heart, Lung, and Blood Institute; August 2007. NIH Publication No. 074051. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed March 5, 2008.
Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma
(GINA). National Institutes of Health. NIH Publication No. 02-3659. National Heart,
Lung, and Blood Institute (NHLBI) 2005. http://www.ginasthma.com. Accessed March
14, 2008.
Global Initiative for Asthma (GINA). 2012 Update:global strategy for asthma
management

and

prevention.

Available

from:

http://www.ginasthma.org/

documents/5/documents_variants/37. Accessed May 16, 2014.

Illi S, von ME, Lau S, Niggemann B,Gruber C, Wahn U. Perennial allergen sensitisation
early in life and chronic asthma in children: a birth cohort study. Lancet 2006;368:763
770.

Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk
of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med
2000;162:14031406.
Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM et al. A
longitudinal, population-based, cohort study of childhood asthma followed to adulthood.
N Engl J Med 2003;349:14141422
Nickel R, Kulig M, Forster J,Bergmann R, Bauer CP, Lau S et al. Sensitization to hen_s
egg at the age of twelve months is predictive for allergic sensitization to common indoor
and outdoor allergens at the age of three years. J Allergy Clin Immunol 1997;99:613617.
Host A, Andrae S, Charkin S, az-Vazquez C, Dreborg S, Eigenmann PA et al. Allergy
testing in children: why, who, when and how? Allergy 2003;58:559569.
Wood RA. Skin testing: making the most of every prick. Ann Allergy Asthma Immunol
2002;88:347349.
van Asperen PP, Kemp AS, Mellis CM. Skin test reactivity and clinical allergen sensitivity
in infancy. J Allergy Clin Immunol 1984;73:381386.
Menardo JL, Bousquet J, Rodiere M, Astruc J, Michel FB. Skin test reactivity in infancy. J
Allergy Clin Immunol 1985;75:646651.
Guilbert TW, Morgan WJ, Zeiger RS,Bacharier LB, Boehmer SJ, Krawiec M et al. Atopic
characteristics of children with recurrent wheezing at high risk for the development of
childhood asthma. J Allergy Clin Immunol 2004;114:12821287.
Xuan W, Marks GB, Toelle BG, Belousova E, Peat JK, Berry G et al. Risk factors for
onset and remission of atopy, wheeze, and airway hyperresponsiveness.Thorax
2002;57:104109.
Niemeijer NR, de Monchy JG. Agedependency of sensitization to aeroallergens in
asthmatics. Allergy 1992;47:431435.
Fiocchi A, Besana R, Ryden AC, Terracciano L, Andreotti M, Arrigoni S et al. Differential
diagnosis of IgEmediated allergy in young children with wheezing or eczema symptoms
using a single blood test. Ann Allergy Asthma Immunol 2004;93:328333.

Van Der Heijden HH, Brouwer ML, Hoekstra F, Van Der Pol P, Merkus PJ. Reference
values of exhaled nitric oxide in healthy children 1-5 years using off-line tidal breathing.
Pediatr Pulmonol 2014;49:291-5.
Savenije OE, Kerkhof M, Koppelman GH, Postma DS. Predicting who will have asthma
at school age among preschool children. J Allergy Clin Immunol 2012;130:325-31.
National Heart, Lung, and Blood Institute. Expert Panel Report 3 (EPR3): guidelines for
the diagnosis and management of asthma. Full report, 2007. Available from:
http://www.nhlbi.nih.gov/guidelines/asthma/ asthgdln.pdf. Accessed May 16, 2014.
Friedman

T.

Diagnosing

asthma

in

young

children:

current

research

and

recommendations. J Pediatr Health Care 2010;24:30511.

Bacharier LB, Gilbert TW. Diagnosis and management of early asthma in preschool-aged
children. J Allergy Clin Immunol 2012;130:28796.
Guilbert TW. Identifying and managing the infant and toddler at risk for asthma. J Allergy
Clin Immunol 2010;126:41722.
Doherty G, Bush A. Diagnosing respiratory problems in young children. Practitioner
2007;251:20, 2-5.
Bel EH. Clinical phenotypes of asthma. Curr Opin Pulm Med 2004;10:44-50.
Wen el SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006;368:804-13
Martinez FD. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood
asthma. Pediatr Infect Dis J 2003;22 (2 Suppl):S76-82.
Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, et al. A
longitudinal, population-based, cohort study of childhood asthma followed to adulthood.
N Engl J Med 2003;349(15):1414-22.
Taylor DR, Bateman ED, Boulet LP, Boushey HA, BusseWW, Casale TB, Chanez P,
Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O'Byrne
PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Szefler SJ, Sullivan SD,
Thomas MD,Wenzel SE, Reddel HK. A new perspective on concepts of asthma severity
and control. Eur Respir J 2008;32:545-54.

Cockcroft DW, Swystun VA. Asthma control versus asthma severity J Allergy Clin
Immunol 1996;98:1016-8.
Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH, Sullivan SD. Asthma
control, severity, and quality of life: quantifying the effect of uncontrolled disease. J
Allergy Clin Immunol 2007;120:396-402.
Green RH, Brightling CE, McKenna S, Hargadon B, Parker D,Bradding P, et al. Asthma
exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet
2002;360(9347):1715-21.
Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR.Use of exhaled nitric oxide
measurements to guide treatment in chronic asthma. N Engl J Med 2005;352(21):2163-73.
Khalili B, Boggs PB, Shi R, Bahna SL. Discrepancy between clinical asthma control
assessment tools and fractional exhaled nitric oxide. Ann Allergy Asthma Immunol
2008;101:124-9.
Bisgaard H, Allen D, Milanowski J, Kalev I, Willits L, Davies P. Twelve-month safety and
efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent
wheezing. Pediatrics 2004;113:e87-94.
Bisgaard H. Delivery of inhaled medication to children. J Asthma 1997;34(6):443-67.
Pedersen S. Inhalers and nebulizers: which to choose and why. Respir Med
1996;90(2):69-77.
Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. Device
selection and outcomes of aerosol therapy: Evidence-based guidelines: American College
of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest
2005;127(1):335-71.
Ducharme FM, Lemire C, Noya FJ, et al. Preemptive use of high-dose fluticasone for
virus-induced wheezing in young children. N Engl J Med 2009;360:339-53.
Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled
corticosteroids in infants with episodic wheezing. N Engl J Med 2006;354:1998-2005.

Wilson NM, Silverman M. Treatment of acute, episodic asthma in preschool children

using intermittent high dose inhaled steroids at home. Arch Dis Child 1990;65:407-10.
Williams SJ, Winner SJ, Clark TJ. Comparison of inhaled and intravenous terbutaline in
acute severe asthma. Thorax 1981;36:629-32.
Juniper EF, Svensson K, O'Byrne PM, et al. Asthma quality of life during 1 year of
treatment with budesonide with or without formoterol. Eur Respir J 1999;14:1038-43.
Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE.
Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway
hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev
Respir Dis 1990;142:832-6.
Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide
on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy
(FACET) International Study Group. N Engl J Med 1997;337:1405-11.
O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and
formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit
Care Med 2001;164(8 Pt 1):1392-7.
Adams NP, Bestall JB, Malouf R, Lasserson TJ, Jones PW. Inhaled beclomethasone versus
placebo for chronic asthma. Cochrane Database Syst Rev 2005:CD002738.
Pauwels RA, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild
persistent asthma: a randomised, double-blind trial. Lancet 2003;361:1071-6.
Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and
the prevention of death from asthma. N Engl J Med 2000;343:
The Childhood Asthma Management Program Research Group. Long-term effects of
budesonide or nedocromil in children with asthma. . N Engl J Med 2000;343:1054-63.
Rank MA, Hagan JB, Park MA, et al. The risk of asthma exacerbation after stopping lowdose inhaled corticosteroids: a systematic review and meta-analysis of randomized
controlled trials. J Allergy Clin Immunol 2013;131:724-9.

Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung
function decline in asthma. Eur Respir J 2007;30:452-6.
O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW. Severe exacerbations and
decline in lung function in asthma. Am J Respir Crit Care Med 2009;179:19-24.
Nielsen KG, Bisgaard H. The effect of inhaled budesonide on symptoms, lung function,
and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children. Am J
Respir Crit Care Med 2000;162:1500-6.
Roorda RJ, Mezei G, Bisgaard H, Maden C. Response of preschool children with asthma
symptoms to fluticasone propionate. J Allergy Clin Immunol 2001;108:540-6.
Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool
children at high risk for asthma. N Engl J Med 2006;354:1985-97.
Connett G, Lenney W. Prevention of viral induced asthma attacks using inhaled
budesonide. Arch Dis Child 1993;68:85-7.
Baker JW, Mellon M, Wald J, Welch M, Cruz-Rivera M, Walton-Bowen K. A multipledosing, placebo-controlled study of budesonide inhalation suspension given once or twice
daily for treatment of persistent asthma in young children and infants. Pediatrics
1999;103:414-21.
Teper AM, Colom AJ, Kofman CD, Maffey AF, Vidaurreta SM, Bergada I. Effects of
inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing.
Pediatr Pulmonol 2004;37:111-5.
Bisgaard H, Gillies J, Groenewald M, Maden C. The effect of inhaled fluticasone
propionate in the treatment of young asthmatic children: a dose comparison study. Am J
Respir Crit Care Med 1999;160:126-31.
Chavasse RJ, Bastian-Lee Y, Richter H, Hilliard T, Seddon P. Persistent wheezing in
infants with an atopic tendency responds to inhaled fluticasone. Arch Dis Child
2001;85:143-8.
Hofhuis W, van der Wiel EC, Nieuwhof EM, et al. Efficacy of fluticasone propionate on
lung function and symptoms in wheezy infants. Am J Respir Crit Care Med
2005;171:328-33.

Ilangovan P, Pedersen S, Godfrey S, Nikander K, Noviski N, Warner JO. Treatment of

severe steroid dependent preschool asthma with nebulised budesonide suspension. Arch
Dis Child 1993;68:356-9.
Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A. Secondary prevention of
asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): doubleblind, randomised, controlled study. Lancet 2006;368:754-62.
Pao CS, McKenzie SA. Randomized controlled trial of fluticasone in preschool children
with intermittent wheeze. Am J Respir Crit Care Med 2002;166:945-9.
Crocker DD, Kinyota S, Dumitru GG, et al. Effectiveness of home-based, multi-trigger,
multicomponent interventions with an environmental focus for reducing asthma
morbidity: a community guide systematic review. Am J Prev Med 2011;41:S5-32.
Morgan WJ, Crain EF, Gruchalla RS, et al. Results of a home-based environmental
intervention among urban children with asthma. N Engl J Med 2004;351:1068-80.
Custovic A, Green R, Taggart SC, et al. Domestic allergens in public places. II: Dog (Can
f1) and cockroach (Bla g 2) allergens in dust and mite, cat, dog and cockroach allergens in
the air in public buildings. Clin Exp Allergy 1996;26:1246-52.
Chauhan BF, Ducharme FM. Anti-leukotriene agents compared to inhaled corticosteroids
in the management of recurrent and/or chronic asthma in adults and children. Cochrane
Database Syst Rev 2012;5:CD002314.
Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses
to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol
2005;115:233-42.
Ostrom NK, Decotiis BA, Lincourt WR, et al. Comparative efficacy and safety of lowdose fluticasone propionate and montelukast in children with persistent asthma. J Pediatr
2005;147:213-20.
Garcia Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P. Montelukast,
compared with fluticasone, for control of asthma among 6- to 14-year-old patients with
mild asthma: the MOSAIC study. Pediatrics 2005;116:360-9.

Castro-Rodriguez JA, Rodrigo GJ. The role of inhaled corticosteroids and montelukast in
children with mildmoderate asthma: results of a systematic review with meta-analysis.
Arch Dis Child 2010;95:365-70.
Dicpinigaitis PV, Dobkin JB, Reichel J. Antitussive effect of the leukotriene receptor
antagonist zafirlukast in subjects with cough-variant asthma. J Asthma 2002;39:291-7.
Barnes NC, Miller CJ. Effect of leukotriene receptor antagonist therapy on the risk of
asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of
zafirlukast trials. Thorax 2000;55:478-83.
Drazen JM. Asthma therapy with agents preventing leukotriene synthesis or action. Proc
Assoc Am Physicians 1999;111:547-59.
Lipworth BJ. Leukotriene-receptor antagonists. Lancet 1999;353:57-62.
Swern AS, Tozzi CA, Knorr B, Bisgaard H. Predicting an asthma exacerbation in children
2 to 5 years of age. Ann Allergy Asthma Immunol 2008;101:626-30.
Brunette MG, Lands L, Thibodeau LP. Childhood asthma: prevention of attacks with
short-term

corticosteroid

treatment

of

upper

respiratory

tract

infection.

Pediatrics1988;81:624-9.
Fox GF, Marsh MJ, Milner AD. Treatment of recurrent acute wheezing episodes in
infancy with oral salbutamol and prednisolone. Eur J Pediatr 1996;155:512-6.
Grant CC, Duggan AK, DeAngelis C. Independent parental administration of prednisone
in acute asthma: a double-blind, placebo-controlled, crossover study. Pediatrics
1995;96:224-9.
Oommen A, Lambert PC, Grigg J. Efficacy of a short course of parent-initiated oral
prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial.
Lancet 2003;362:1433-8.
Vuillermin P, South M, Robertson C. Parent-initiated oral corticosteroid therapy for
intermittent wheezing illnesses in children. Cochrane Database Syst Rev 2006:CD005311.
Ducharme FM, Lemire C, Noya FJ, et al. Preemptive use of high-dose fluticasone for
virus-induced wheezing in young children. N Engl J Med 2009;360:339-53.

Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled

corticosteroids in infants with episodic wheezing. N Engl J Med 2006;354:1998-2005
Wilson NM, Silverman M. Treatment of acute, episodic asthma in preschool children
using intermittent high dose inhaled steroids at home. Arch Dis Child 1990;65:407-10.
Connett G, Lenney W. Prevention of viral induced asthma attacks using inhaled
budesonide. Arch Dis Child 1993;68:85-7.
Svedmyr J, Nyberg E, Thunqvist P, Asbrink-Nilsson E, Hedlin G. Prophylactic
intermittent treatment with inhaled corticosteroids of asthma exacerbations due to airway
infections in toddlers. Acta Paediatr 1999;88:42-7.
Zeiger RS, Mauger D, Bacharier LB, et al. Daily or intermittent budesonide in preschool
children with recurrent wheezing. N Engl J Med 2011;365:1990-2001.
Geelhoed GC, Landau LI, Le Souef PN. Evaluation of SaO2 as a predictor of outcome in
280 children presenting with acute asthma. Ann Emerg Med 1994;23:1236-41.
Castro-Rodriguez JA, Rodrigo GJ. Beta-agonists through metered-dose inhaler with
valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in
children under 5 years of age: a systematic review with meta-analysis. J Pediatr
2004;145:172-7.
Deerojanawong J, Manuyakorn W, Prapphal N, Harnruthakorn C, Sritippayawan S,
Samransamruajkit R. Randomized controlled trial of salbutamol aerosol therapy via
metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing. Pediatr
Pulmonol 2005;39:466-72.
Griffiths B, Ducharme FM. Combined inhaled anticholinergics and short-acting beta2agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev
2013;8:CD000060.
Arshad SH. Primary prevention of asthma and allergy. J Allergy Clin Immunol
2005;116(1):3-14.
Friedman NJ, Zeiger RS. The role of breast-feeding in the development of allergies and
asthma. J Allergy Clin Immunol 2005;115(6):1238-48.

Gdalevich M, Mimouni D, Mimouni M. Breast-feeding and the risk of bronchial asthma

in childhood: a systematic review with meta-analysis of prospective studies. J Pediatr
2001;139(2):261-6 Immunol 2006;6:146-51.
Nurmatov U, Devereux G, Sheikh A. Nutrients and foods for the primary prevention of
asthma and allergy: systematic review and meta-analysis. J Allergy Clin Immunol
2011;127:724-33.e1-30.
Martine FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and
wheezing in the first six years of life. The Group Health Medical Associates. N Engl J
Med 1995;332(3):133-8.
Dezateux C, Stocks J, Dundas I, Fletcher ME. Impaired airway function and wheezing in
infancy: the influence of maternal smoking and a genetic predisposition to asthma. Am J
Respir Crit Care Med 1999;159(2):403-10.
Strachan DP, Cook DG. Health effects of passive smoking. 5. Parental smoking and
allergic sensitisation in children. Thorax 1998;53(2):117-23.
Strachan DP, Cook DG. Health effects of passive smoking. 1. Parental smoking and lower
respiratory illness in infancy and early childhood. Thorax 1997;52(10):905-14.
Eggleston PA. Improving indoor environments:reducing allergen exposures.J Allergy Clin
Immunol 2005;116:122-126.
Gold MS, Kemp AS. Atopic disease in childhood. Med J Aust 2005;182:298304.
Haahtela T, Holgate S, Pawankar R, et al. The biodiversity hypothesis and allergic disease:
world allergy organization position statement. World Allergy Org J 2013;6:3.
Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming in early life and
development of asthma and allergy: a cross-sectional survey. Lancet 2001;358:1129-33.
Braun-Fahrlander C, Riedler J, Herz U, et al. Environmental exposure to endotoxin and its
relation to asthma in school-age children. N Engl J Med 2002;347:869-77.
Karvonen AM, Hyvarinen A, Gehring U, et al. Exposure to microbial agents in house dust
and wheezing, atopic dermatitis and atopic sensitization in early childhood: a birth cohort
study in rural areas. Clin Exp Allergy 2012;42:1246-56.

Ownby DR, Johnson CC, Peterson EL. Exposure to dogs and cats in the first year of life
and risk of allergic sensitization at 6 to 7 years of age. JAMA 2002;288:963-72.
Thavagnanam S, Fleming J, Bromley A, Shields MD, Cardwell CR. A meta-analysis of
the association between Caesarean section and childhood asthma. Clin Exp Allergy
2008;38:629-33.
Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ Asthma and
wheezing in the first six years of life N Engl J Med 1995;332:133-8
Bousquet J, Kiley J, Bateman ED, et al: Prioritised research agenda for prevention and
control of chronic respiratory diseases. Eur Respir J 2010, 36:9951001.
Dawn L. DeMeo and Scott t. Weiss et al.; Asthma and COPD, Second Edition USA 2009.`
Rabe KF, Adachi M, Lai CK, et al.Worldwide severity and control of asthma in children
and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol
2004;114(1):40e7.
Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma
patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006;6:13.
FitzGerald JM, Boulet LP, McIvor RA, Zimmerman S, Chapman KR. Asthma control in
Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J
2006; 13(5):253e9.
Accordini S, Corsico A, Cerveri I, et al. The socio-economic burden of asthma is
substantial in Europe. Allergy 2008;63(1): 116e24.
Accordini S, Bugiani M, Arossa W, et al. Poor control increases the economic cost of
asthma.

multicentre

population-based

study.

Int

Arch

Allergy

Immunol

2006;141(2):189e98.
Hoskins G, McCowan C, Neville RG, Thomas GE, Smith B, Silverman S: Risk factors
and costs associated with an asthma attack. Thorax 2000, 55(1):19-24.
NIH Publication No. 02-5074. Bethesda, MD, U.S. Department of Health and Human
Services; National Institutes of Health; National Heart, Lung, and Blood Institute;
National Asthma Education and Prevention Program, June 2003.

Nicholson PJ, Cullinan P, Taylor AJ, Burge PS, Boyle C. Evidence based guidelines for
the prevention, identification, and management of occupational asthma. Occup Environ
Med 2005;62(5):290-9.
A.ten Brinke, P. J. Sterk, A. A. M. Masclee, P. Spinhoven, J. T. Schmidt, A. H.
Zwinderman, K. F. Rabe E. H. Bel. Risk factors of frequent exacerbations in difficult-totreat asthma. Eur Respir J 2005; 26:812-818
Von Mutius E, Illi s, Hirsch T, Leupold W, Keil U, Weuland SK Frequency of infection
and risk of asthma, atopy and airway hyperresponsivenessin children. Eur Respir J,
1999:14:4-11.
Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al. Interpretative
strategies for lung function tests. Eur.Respir.J. 2005;26:948-68.
Leynaert B, Bousquet J, Neukirch C, Liard R, et al. Perennial rhinitis: an independent risk
factor for asthma in nonatopic subjects: results from the European Community
Respiratory Health Survey. J Allergy Clin Immunol 1999;104:301-4.
Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with
decreased asthma stability. Eur Respir J 2002;19(2):246e51.
Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma
(ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN
and AllerGen). Allergy 2008;63(Suppl. 86):8e160.
Thomas M, Kocevar VS, Zhang Q, Yin DD, Price D. Asthmarelated health care resource
use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics
2005;115(1):129e34.
Rabe KF, Adachi M, Lai CK, et al.Worldwide severity and control of asthma in children
and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol
2004;114(1):40e7.
Rau JL. Determinants of patient adherence to an aerosol regimen. Respir Care
2005;50(10):1346e56.